HGENQ — Humanigen Share News
0.000.00%
Last trade - 00:00- $0.00m
- -$3.10m
- $2.51m
U.S. STOCKS ON THE MOVE-Novavax, Metacrine, Corsair, Entasis
-Humanigen: Rises on UK application for rolling review of COVID-19 therapy
U.S. STOCKS ON THE MOVE-Salesforce, Yext, Riot Blockchain, Vertex Energy
Brief: Humanigen Submits Application To FDA For Emergency Use Authorization For Lenzilumab In COVID-19
Humanigen: Rises after filing emergency use application for COVID-19 treatment
U.S. STOCKS ON THE MOVE-Nuvve, FreightCar America, Harley Davidson, Home Depot
Humanigen: Rises on manufacturing agreement for COVID-19 therapy
Brief: Humanigen And Chime Biologics Enter Into Manufacturing Agreement For Covid-19 Therapeutic Candidate Lenzilumab
Humanigen Inc reports results for the quarter ended in March - Earnings Summary
Brief: Humanigen Reports Q1 Loss Per Share $1.25
Covid Science: New antibody drug helps patients breathe; virus may insert genetic fragments into genetic code
Humanigen: Rises on publication of data from COVID-19 treatment trial
Humanigen: Falls on terminating blood cancer study agreement with Gilead
Brief: Humanigen Reports Positive Data With Lenzilumab In The Zuma-19 CAR-T Phase 1B Study In DLBCL And Plans To Initiate Potential Registrational Study
Brief: Humanigen Announces Positive Results From Phase 1 Study Of Ifabotuzumab In Glioblastoma Multiforme
U.S. STOCKS ON THE MOVE-Chewy, VirTra, Walgreens, ProPhase
U.S. STOCKS ON THE MOVE-Chewy, VirTra, Blackberry, Humanigen
Humanigen: Down on discounted share offering
Brief: Humanigen Announces Pricing Of Public Offering Of Five Million Shares Of Common Stock